Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Schulz

Showing results (861-870 of 906) with videos related to

Pageof 91
Sort By:
The Lancet. Neurology|August 22, 2020
Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort studyHeike Jacobi, Sophie Tezenas du Montcel, Sandro Romanzetti, et al.
The New England Journal of Medicine|June 15, 2012
Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreakClaudio U Köser, Matthew T G Holden, Matthew J Ellington, et al.
European Journal of Neurology|January 11, 2025
Longitudinal analysis of anthropometric measures over 5 years in patients with Friedreich ataxia in the EFACTS natural history studyStella Andrea Lischewski, Kerstin Konrad, Imis Dogan, et al.
Cerebellum (London, England)|June 23, 2026
Transitional Life Events in Friedreich Ataxia: Differential Age at Onset PerspectivesAudrey Iskandar, Maresa Buchholz, Dorota Sarwinska, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 20, 2021
Cognitive profiles of patients with mild cognitive impairment due to Alzheimer's versus Parkinson's disease defined using a base rate approach: Implications for neuropsychological assessmentsAnja Ophey, Steffen Wolfsgruber, Sandra Roeske, et al.
Parkinsonism & Related Disorders|June 21, 2016
Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's diseaseDavid Mengel, Judith Dams, Jannis Ziemek, et al.
Orphanet Journal of Rare Diseases|February 12, 2024
Recommendations for optimal interdisciplinary management and healthcare settings for patients with rare neurological diseasesHolm Graessner, Carola Reinhard, Tobias Bäumer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 10, 2018
Cognitive decline in Parkinson's disease: the impact of the motor phenotype on cognitionJennifer Wojtala, Ines Ann Heber, Petra Neuser, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 23, 2010
Self-rated health status in spinocerebellar ataxia--results from a European multicenter studyTanja Schmitz-Hübsch, Mathieu Coudert, Paola Giunti, et al.
Neuroepidemiology|November 10, 2011
Parkinson's disease and dementia: a longitudinal study (DEMPARK)Monika Balzer-Geldsetzer, Ana Sofia Ferreira Braga da Costa, Martin Kronenbürger, et al.
Pageof 91

Showing results (861-870 of 906) with videos related to

Sort By:
Pageof 91
The Lancet. Neurology|August 22, 2020
Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort studyHeike Jacobi, Sophie Tezenas du Montcel, Sandro Romanzetti, et al.
The New England Journal of Medicine|June 15, 2012
Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreakClaudio U Köser, Matthew T G Holden, Matthew J Ellington, et al.
European Journal of Neurology|January 11, 2025
Longitudinal analysis of anthropometric measures over 5 years in patients with Friedreich ataxia in the EFACTS natural history studyStella Andrea Lischewski, Kerstin Konrad, Imis Dogan, et al.
Cerebellum (London, England)|June 23, 2026
Transitional Life Events in Friedreich Ataxia: Differential Age at Onset PerspectivesAudrey Iskandar, Maresa Buchholz, Dorota Sarwinska, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 20, 2021
Cognitive profiles of patients with mild cognitive impairment due to Alzheimer's versus Parkinson's disease defined using a base rate approach: Implications for neuropsychological assessmentsAnja Ophey, Steffen Wolfsgruber, Sandra Roeske, et al.
Parkinsonism & Related Disorders|June 21, 2016
Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's diseaseDavid Mengel, Judith Dams, Jannis Ziemek, et al.
Orphanet Journal of Rare Diseases|February 12, 2024
Recommendations for optimal interdisciplinary management and healthcare settings for patients with rare neurological diseasesHolm Graessner, Carola Reinhard, Tobias Bäumer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 10, 2018
Cognitive decline in Parkinson's disease: the impact of the motor phenotype on cognitionJennifer Wojtala, Ines Ann Heber, Petra Neuser, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 23, 2010
Self-rated health status in spinocerebellar ataxia--results from a European multicenter studyTanja Schmitz-Hübsch, Mathieu Coudert, Paola Giunti, et al.
Neuroepidemiology|November 10, 2011
Parkinson's disease and dementia: a longitudinal study (DEMPARK)Monika Balzer-Geldsetzer, Ana Sofia Ferreira Braga da Costa, Martin Kronenbürger, et al.
Pageof 91